April 18, 2024 - Puma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial Results
Mar. 20, 2024 - Puma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast Cancer |
Upcoming EventsMay 2, 2024 - Puma Biotechnology 1Q-2024 Financial Results Conference Call More Past EventsMar. 6, 2024 - TD Cowen’s 44th Annual Health Care ConferenceMore Feb. 29, 2024 - Puma Biotechnology 4Q-2023 Financial Results Conference Call More Jan. 11, 2024 - B. Riley Securities 4th Annual Oncology Conference More Dec. 11, 2023 - Puma Biotechnology Corporate Presentation More Nov. 2, 2023 - Puma Biotechnology 3Q-2023 Financial Results Conference Call More Oct. 11-15, 2023 - AACR-NCI-EORTC International Conference More |
Annual Report Archives Puma Biotechnology, Inc. 10880 Wilshire Blvd., Suite 2150 Los Angeles, CA 90024 424-248-6500 Main 424-248-6501 Fax Medical Inquiries: 1-844-MED-PUMA (1-844-633-7862), or medinfo@pumabiotechnology.com Business Development: info@pumabiotechnology.com Investor Relations: ir@pumabiotechnology.com Follow Us: |
© 2024 Puma Biotechnology, Inc. | Privacy Policy | WA Privacy Policy | Terms of Service | Data Rights Request | Legal Notice | Site Map |